Loading...
Clinical outcome and molecular characterisation of chemorefractory metastatic colorectal cancer patients with long-term efficacy of regorafenib treatment
BACKGROUND: To investigate the potential predictors of response to regorafenib, in chemorefractory metastatic colorectal cancer (mCRC) patients with long-term efficacy from regorafenib treatment. METHODS: Retrospective, single institution analysis of patients with chemorefractory mCRC treated with r...
Saved in:
Published in: | ESMO Open |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
Format: | Artigo |
Language: | Inglês |
Published: |
ESMO Open
2017
|
Subjects: | |
Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5703385/ https://ncbi.nlm.nih.gov/pubmed/29211816 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2017-000177 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|